Common side effects during the adjustment period (typically the first 24 weeks): Mild nausea usually less intense than when first starting a GLP-1 medication Changes in appetite (some patients notice less appetite suppression early on at the starting 0.25 mg dose) Mild stomach discomfort, bloating, or constipation Injection site reactions Side effects that are less likely during the switch (compared to first-time GLP-1 use), but still possible: Significant vomiting less common given prior GLP-1 exposure, but possible Hypoglycemia particularly relevant for type 2 diabetes patients on insulin or sulfonylureas
If your study design requires longer peptide availability, reconstitute smaller volumes more frequently rather than extending expiration timelines
Innovations in peptide synthesis and design are leading to the development of more potent and selective peptides with improved safety profiles
Wegovy dosing schedule and what to expect Managing side effects and tips that work Pricing, delivery, and how to get started Understanding Wegovy and How It Works Wegovy (semaglutide 2.4 mg) is a prescription medicine licensed in the UK for weight management in adults with obesity or those who are overweight with at least one weight-related comorbidity
The trailing air bubble creates a small cushion that prevents drug leakage into skin tissue as the needle is withdrawn
For the first time ever, Gabby didnt need an afternoon nap to make it through the day and best yet, she could now keep up with her young kids